Ashland Inc.
ASH- Exchange
- NYSE
- Industry
- Wholesale-Chemicals & Allied Products
- SEC CIK
- 0001674862
No open-market purchases or sales by Ashland Inc. insiders were filed in the last 90 days; 357 institutions reported holding it in 13F filings for Q2 2026, worth $3.44B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Ashland Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Ashland Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Musa Osama M | SVP and CTO | 37,577 | Sep 23, 2026 | 6 |
| Lampkin Robin E. | SVP, GC & Secretary | 6,299 | Aug 12, 2026 | 4 |
| Thomas Peter T | Director | – | Aug 5, 2026 | 1 |
| Spizzo Allen A | Director | – | Aug 5, 2026 | 1 |
| Assis Alessandra Faccin | SVP and GM, Life Sciences | 8,215 | Jul 29, 2026 | 3 |
| Chattopadhyay Sanat | Director | – | Jul 1, 2026 | 5 |
| Bishop Steven D | Director | – | Jul 1, 2026 | 5 |
| Loy Bertrand | Director | – | May 18, 2026 | 1 |
| Minicucci James P. | SVP and GM, Personal Care | 7,221 | May 11, 2026 | 3 |
| Novo Guillermo | Chair of the Board and CEO | 140,849 | Feb 10, 2026 | 4 |
| Harrison Suzan F. | Director | 1,931 | Jan 22, 2026 | 1 |
| Kulkarni Ashish K | Director | 2,113 | Jan 22, 2026 | 1 |
| Main Sue | Director | – | Jan 21, 2026 | 1 |
| Peribere Jerome A | Director | – | Jan 21, 2026 | 1 |
| Tozier Scott | Director | – | Jan 21, 2026 | 1 |
| Drury Eileen | SVP and Chief HRO | 7,601 | Nov 21, 2025 | 3 |
| Caceres Dago | SVP & GM, Specialty Additives | 531 | Nov 21, 2025 | 2 |
| Whitaker William | SVP, CFO & PFO | 2,049 | Nov 21, 2025 | 3 |
| Richardson Samuel | VP, Controller and PAO | 1,072 | Nov 21, 2025 | 3 |
| Pedreiro Sergio | Director | – | Jan 23, 2025 | 0 |
| Teal Janice | Director | – | Jan 2, 2025 | 0 |
| Boni Eric N | VP, Finance & Prinpl Acctg Off | 14,633 | Dec 9, 2024 | 0 |
| Willis J Kevin | SVP and CFO | 232,716 | Nov 20, 2024 | 0 |
| Bostaph Karl R. | Senior VP Operations | 7,012 | Nov 20, 2024 | 0 |
| Joseph Wetteny | Director | – | Jan 25, 2024 | 0 |
| Chong Min | SVP, Gen. Mgr. | 12,723 | Jan 11, 2024 | 0 |
| Ashland LLC | SVP, OPERATIONS | 5,268 | Nov 22, 2023 | 0 |
| Ashland Inc. | Sr. Vice President | 19,437 | Nov 22, 2023 | 0 |
| Kalyana Swaminathan Ashok | See Remarks | 3,359 | Nov 22, 2023 | 0 |
| Wang Xiaolan | Sr VP & Gen Mgr, Personal Care | 440 | Feb 24, 2023 | 0 |
| Winkler von Mohrenfels Petra Yvonne | Sr. VP, GC and Secretary | 6,139 | Feb 13, 2023 | 0 |
| Ihlenfeld Jay V | Director | – | Jan 26, 2023 | 0 |
| Cummins Brendan | Director | – | Jan 26, 2023 | 0 |
| Dempsey William G | Director | – | Jan 4, 2023 | 0 |
| Eminence Capital, LP | Director, Other: See Remarks | 4,083,978Indirect | Sep 6, 2022 | 0 |
| Sandler Ricky C | Director, Other: See Remarks | 4,083,978Indirect | Sep 6, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2025 (view filing) | Jan 31 | 3 days | Novo GuillermoChair of the Board and CEO | PPurchase | +31.3K | $64.24 | +$2.01M | New position31.3K after | |
| Feb 3, 2025 (view filing) | Jan 31 | 3 days | Assis Alessandra FaccinSVP and GM, Life Sciences | PPurchase | +3.15K | $64.00 | +$201.6K | New position3.15K after | |
| Dec 9, 2024 (view filing) | Dec 5 | 4 days | Boni Eric NVP, Finance & Prinpl Acctg Off | SSale | −451 | $78.07 | −$35.2K | −3.1%14.2K after | 10b5-1 |
| Nov 20, 2024 (view filing) | Nov 19 | 1 day | Lampkin Robin E.SVP, Gen Counsel and Secrty. | SSale | −162 | $75.54 | −$12.2K | −4.6%3.35K after | 10b5-1 |
| Nov 18, 2024 (view filing) | Nov 15 | 3 days | Lampkin Robin E.SVP, Gen Counsel and Secrty. | SSale | −868 | $77.90 | −$67.6K | −23.1%2.88K after | 10b5-1 |
| Feb 20, 2024 (view filing) | Feb 16 | 4 days | Lampkin Robin E.SVP, Gen Counsel and Secrty. | SSale | −844 | $92.54 | −$78.1K | −22.6%2.88K after | 10b5-1 |
| Dec 8, 2023 (view filing) | Dec 7 | 1 day | Boni Eric NPrincipal Accounting Officer | SSale | −843 | $82.38 | −$69.4K | −6.1%13.1K after | 10b5-1 |
| Sep 6, 2022 (view filing)4:15 PM ET | Sep 1 | 5 days | Eminence Capital, LP and 1 otherDirector, Other: See Remarks | PPurchaseCommon Stock, par value $0.01 per share ("Common Stock") | +224.2K | $100.20 | +$22.5M | +5.8%4.08M after | |
| Sep 6, 2022 (view filing)4:15 PM ET | Sep 1 | 5 days | Eminence Capital, LP and 1 otherDirector, Other: See Remarks | SSale | −224.2K | $100.20 | −$22.5M | −5.2%4.08M after | |
| Jun 9, 2022 (view filing) | Jun 8 | 1 day | Boni Eric NPrincipal Accounting Officer | SSale | −2.66K | $109.50 | −$290.9K | −20.0%10.6K after | |
| Jun 3, 2022 (view filing) | Jun 2 | 1 day | Willis J KevinSr.VP &Chief Financial Officer | SSale | −4.24K | $105.58 | −$447.1K | −51.0%4.07K after | 2 lots |
| May 19, 2022 (view filing)4:15 PM ET | May 17 | 2 days | Eminence Capital, LP and 1 otherDirector | PPurchaseCommon Stock, par value $0.01 per share ("Common Stock") | +48.8K | $101.27 | +$4.94M | +1.2%4.08M after | |
| Sep 13, 2021 (view filing) | Sep 10 | 3 days | Willis J KevinChief Financial Officer | SSale | −1.10K | $94.30 | −$104.1K | −57.2%825 after |